Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Avrobio, Inc. (AVRO)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Avrobio, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Avrobio, Inc. since 2005.
The reporting company's ticker symbol is AVRO. The reporting company's CIK number is 1681087.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $641,714.
The total value of stock option exercises since 2005 is $11,777.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-04-08||Paige Christopher (Director)||Sale||2,500||26.38||65,952|
|2019-04-08||Mackay Geoffrey (See Remarks)||Sale||698||27.07||18,893|
|2019-04-05||Paige Christopher (Director)||Sale||7,500||25.90||194,257|
|2019-04-05||Mackay Geoffrey (See Remarks)||Sale||13,302||27.26||362,612|
|2018-10-08||Kreher Nerissa (Chief Medical Officer)||Option Ex||2,942||.91||2,677|
|2018-10-08||Dorton Katina (Chief Financial Officer)||Option Ex||10,000||.91||9,100|
Insider trading activities including stock purchases, stock sales, and option exercises of AVRO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Avrobio, Inc. (symbol AVRO, CIK number 1681087) see the Securities and Exchange Commission (SEC) website.